253 related articles for article (PubMed ID: 11177300)
41. Effects of renal transplantation on hyperlipidemia and high-density lipoprotein cholesterol (HDL).
Curtis JJ; Galla JH; Woodford SY; Rees ED; Luke RG
Transplantation; 1978 Nov; 26(5):364-6. PubMed ID: 212852
[No Abstract] [Full Text] [Related]
42. High-density lipoprotein composition and paraoxonase activity in Type I diabetes.
Valabhji J; McColl AJ; Schachter M; Dhanjil S; Richmond W; Elkeles RS
Clin Sci (Lond); 2001 Dec; 101(6):659-70. PubMed ID: 11724654
[TBL] [Abstract][Full Text] [Related]
43. High-density lipoproteins in human health and disease.
Glomset JA
Adv Intern Med; 1980; 25():91-116. PubMed ID: 6987852
[No Abstract] [Full Text] [Related]
44. Lipid abnormalities in coronary heart disease: a population-based case-control study.
Gupta R; Kaul V; Prakash H; Sarna M; Singhal S; Gupta VP
Indian Heart J; 2001; 53(3):332-6. PubMed ID: 11516034
[TBL] [Abstract][Full Text] [Related]
45. Serum sex hormones in premenopausal women with coronary heart disease.
Mohamad MJ; Karayyem M; Mohammad MA; Al-Alami J; Al-Hader A
Neuro Endocrinol Lett; 2006 Dec; 27(6):758-62. PubMed ID: 17186999
[TBL] [Abstract][Full Text] [Related]
46. [High and low density lipoprotein abnormalities in coronary patients with LDL-C at target and uncontrolled HDL-C and triglycerides].
Posadas-Romero C; Posadas-Sánchez R; Juárez-Rojas JG; Medina-Urrutia A; Jorge-Galarza E; Cardoso-Saldaña G; Caracas-Portilla N; Mendoza-Peŕez E
Arch Cardiol Mex; 2008; 78(1):30-9. PubMed ID: 18581711
[TBL] [Abstract][Full Text] [Related]
47. Resolution of hyperlipidemia after laparoscopic Roux-en-Y gastric bypass.
Nguyen NT; Varela E; Sabio A; Tran CL; Stamos M; Wilson SE
J Am Coll Surg; 2006 Jul; 203(1):24-9. PubMed ID: 16798484
[TBL] [Abstract][Full Text] [Related]
48. [Interrelation of diabetes mellitus, atherosclerosis and ischemic heart disease].
Bodnar PN; Donish RM; Pristupiuk AM
Ter Arkh; 1984; 56(10):88-92. PubMed ID: 6523367
[TBL] [Abstract][Full Text] [Related]
49. [Antiatherogenic effect of high density lipoprotein].
Turczyn B; Skoczyńska A
Postepy Hig Med Dosw; 2002; 56(4):499-520. PubMed ID: 12418415
[TBL] [Abstract][Full Text] [Related]
50. [Clearance and protective factors of HDL-cholesterol (author's transl)].
Ageta M; Yamasaki S
Rinsho Byori; 1981 Feb; 29(2):121-30. PubMed ID: 7230529
[No Abstract] [Full Text] [Related]
51. Serum 1H-nuclear magnetic spectroscopy followed by principal component analysis and hierarchical cluster analysis to demonstrate effects of statins on hyperlipidemic patients.
Le Moyec L; Valensi P; Charniot JC; Hantz E; Albertini JP
NMR Biomed; 2005 Nov; 18(7):421-9. PubMed ID: 16075416
[TBL] [Abstract][Full Text] [Related]
52. [Quantitation of cholesterol levels in HDL subfractions (author's transl)].
Irie N; Yano Y; Homma Y; Hara T; Takeuchi I; Nakaya N; Goto Y
Nihon Ronen Igakkai Zasshi; 1980 Nov; 17(6):587-94. PubMed ID: 7206297
[No Abstract] [Full Text] [Related]
53. High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease.
Gotto AM
Am Heart J; 2002 Dec; 144(6 Suppl):S33-42. PubMed ID: 12486414
[TBL] [Abstract][Full Text] [Related]
54. Multiple actions of high-density lipoprotein.
Florentin M; Liberopoulos EN; Wierzbicki AS; Mikhailidis DP
Curr Opin Cardiol; 2008 Jul; 23(4):370-8. PubMed ID: 18520722
[TBL] [Abstract][Full Text] [Related]
55. Variable effects of soy protein on plasma lipids in hyperlipidemic and normolipidemic hemodialysis patients.
Chen ST; Ferng SH; Yang CS; Peng SJ; Lee HR; Chen JR
Am J Kidney Dis; 2005 Dec; 46(6):1099-106. PubMed ID: 16310576
[TBL] [Abstract][Full Text] [Related]
56. Simvastatin and preparation of polyunsaturated phospholipids produce similar changes in the phospholipid composition of high-density lipoproteins during hypercholesterolemia.
Ozerova IN; Akhmedzhanov NM; Perova NV; Paramonova IV
Bull Exp Biol Med; 2005 Feb; 139(2):210-2. PubMed ID: 16027809
[TBL] [Abstract][Full Text] [Related]
57. [Apparent protective effect of high density lipoprotein against coronary heart disease in the elderly].
Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
Zhonghua Yi Xue Za Zhi; 2003 May; 83(10):827-31. PubMed ID: 12895332
[TBL] [Abstract][Full Text] [Related]
58. Hypolipidemic activity of 18beta-glycyrrhetinic acid on streptozotocin-induced diabetic rats.
Kalaiarasi P; Kaviarasan K; Pugalendi KV
Eur J Pharmacol; 2009 Jun; 612(1-3):93-7. PubMed ID: 19361497
[TBL] [Abstract][Full Text] [Related]
59. [Discrimination between the effects of hypolipidemic and antiatherogenic drugs: probucol pharmacokinetics (review of the literature)].
Titov VN; Zaĭtseva TM
Klin Lab Diagn; 2000 Aug; (8):3-9. PubMed ID: 11031423
[No Abstract] [Full Text] [Related]
60. Qualitative effect of fenofibrate and quantitative effect of atorvastatin on LDL profile in combined hyperlipidemia with dense LDL.
Winkler K; Weltzien P; Friedrich I; Schmitz H; Nickell HH; Hauck P; Hoffmann MM; Baumstark MW; Wieland H; März W
Exp Clin Endocrinol Diabetes; 2004 May; 112(5):241-7. PubMed ID: 15146369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
